A perspective view of sodium iodide symporter research and its clinical implications
G Riesco-Eizaguirre… - European Journal of …, 2006 - academic.oup.com
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein that mediates
active iodide transport into the thyroid gland and into several extrathyroidal tissues, in …
active iodide transport into the thyroid gland and into several extrathyroidal tissues, in …
The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies
AR Penheiter, SJ Russell, SK Carlson - Current gene therapy, 2012 - ingentaconnect.com
Preclinical and clinical tomographic imaging systems increasingly are being utilized for non-
invasive imaging of reporter gene products to reveal the distribution of molecular …
invasive imaging of reporter gene products to reveal the distribution of molecular …
Current and potential treatments for cervical cancer
G PC Yee, P de Souza… - Current cancer drug …, 2013 - ingentaconnect.com
Cervical cancer is the third most common carcinoma in women worldwide. Despite
increasing efforts to improve therapy in this disease, a significant proportion of women still …
increasing efforts to improve therapy in this disease, a significant proportion of women still …
Human reporter genes: potential use in clinical studies
I Serganova, V Ponomarev, R Blasberg - Nuclear medicine and biology, 2007 - Elsevier
The clinical application of positron-emission-tomography-based reporter gene imaging will
expand over the next several years. The translation of reporter gene imaging technology into …
expand over the next several years. The translation of reporter gene imaging technology into …
Detecting tumor metastases: the road to therapy starts here
Metastasis is the complex process by which primary tumor cells migrate and establish
secondary tumors in an adjacent or distant location in the body. Early detection of metastatic …
secondary tumors in an adjacent or distant location in the body. Early detection of metastatic …
A novel orally active inverse agonist of estrogen-related receptor gamma (ERRγ), DN200434, a booster of NIS in anaplastic thyroid cancer
TD Singh, J Song, J Kim, J Chin, HD Ji, JE Lee… - Clinical Cancer …, 2019 - AACR
Purpose: New strategies to restore sodium iodide symporter (NIS) expression and function
in radioiodine therapy–refractive anaplastic thyroid cancers (ATCs) are urgently required …
in radioiodine therapy–refractive anaplastic thyroid cancers (ATCs) are urgently required …
Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model
Copper is an essential cofactor for a variety of biochemical processes including oxidative
phosphorylation, cellular antioxidant activity, and elimination of free radicals. The copper …
phosphorylation, cellular antioxidant activity, and elimination of free radicals. The copper …
Sodium Iodide Symporter (NIS)-Mediated Radionuclide (131I, 188Re) Therapy of Liver Cancer After Transcriptionally Targeted Intratumoral in Vivo NIS Gene …
K Klutz, MJ Willhauck, N Wunderlich, C Zach… - Human gene …, 2011 - liebertpub.com
We reported the therapeutic efficacy of 131I in hepatocellular carcinoma (HCC) cells stably
expressing the sodium iodide symporter (NIS) under the control of the tumor-specific α …
expressing the sodium iodide symporter (NIS) under the control of the tumor-specific α …
Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression
MJ Willhauck, BR Sharif Samani… - The Journal of …, 2007 - academic.oup.com
Context: We reported recently the induction of iodide accumulation in prostate cancer cells
(LNCaP) by prostate-specific antigen promoter-directed sodium iodide symporter (NIS) …
(LNCaP) by prostate-specific antigen promoter-directed sodium iodide symporter (NIS) …
Pharmacokinetics and dosimetry of 188Re-pharmaceuticals
G Ferro-Flores, CA de Murphy - Advanced drug delivery reviews, 2008 - Elsevier
The main objective of this review is to apportion current and new insight into the
biodistribution, radiopharmacokinetics, dosimetry and cell targeting of rhenium-188 labeled …
biodistribution, radiopharmacokinetics, dosimetry and cell targeting of rhenium-188 labeled …